companiesandmarkets.com

Return to Report | Print

Premium Company Profile - Celgene

http://www.companiesandmarkets.com/Summary-Company-Profile/premium-company-profile-celgene-41344.asp

Report Summary

Introduction

Celgene is engaged in the discovery, development, and commercialization of therapies for the treatment of cancer and immunological diseases. Among seven marketed products, the company's lead product is Revlimid, an analog of thalidomide that is approved by the FDA for the treatment of MDS patients with the 5q chromosomal deletion and for the treatment of relapsed/refractory myeloma.

Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


    • Highlights

    The company's major contributor to revenue growth during 2002-2006 was product sales which increased at an absolute growth of +$689 million during the period

    During fiscal 2006, the company generated approximately 90.3% of total revenues from product sales. Sales of Thalomid were $433 million during the year whereas Revlimid provided $321 million contributing collectively 84% of the total revenues in 2006

    Celgene's biggest contributor to sales growth out to 2010 will be revenues from Revlimid sales. This is mainly due to the expectation that Revlimid will eventually become the most preferred therapy for multiple myeloma

    Reasons to Purchase

  • Access all the important information and analysis on a company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization

    • Table of Contents

    TABLE OF CONTENTS
    Overview 1
    Catalyst 1
    Summary 1
    Company Structure 6
    Company Overview and Key Facts 6
    Business Description 7
    History 9
    Locations and Subsidiaries 12
    Company Financials 13
    Stock Market Performance 13
    P&L 15
    Balance Sheet 19
    Cash Flow 19
    Business Segment Performance 20
    Geographic Segment Performance 21
    Products & Services 23
    Marketed Products 23
    Pipeline Products 26
    Pipeline Products 26
    Historical Product Sales 29
    AC Forecast Product Sales 30
    Competitors and Strategic Business Relationships 32
    Key Competitors 32
    Key Suppliers 32
    Key Clients 33
    Shareholding Structure 34
    Strategy 35
    Company View 35
    Corporate Strategy 37
    SWOT Analysis 39
    Overview 39
    Strengths 40
    Weaknesses 42
    Opportunities 43
    Threats 45
    Value Chain Analysis 46
    Overview 46
    Discovery and Product Development 46
    Manufacturing 47
    Sales 47
    Scorecard 48
    Overview 48
    Scorecard Analysis 49
    Key Employees 50
    List of Key Employees 50
    Key Employee Biographies 51
    Financial and Operational Overview 55
    Financial and Operational Overview 55
    Key Industry Specific Ratios 57
    APPENDIX 58
    Ask the analyst 58
    Datamonitor consulting 58
    Disclaimer 58


    TABLE OF FIGURES
    Figure 1: Celgene - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 17
    Figure 2: Celgene - Key Strategic Revenues, 2002-2006 ($ Mn) 21
    Figure 3: Celgene - Key Strategic Revenues, 2006-2010 ($ Mn) 31


    TABLE OF TABLES
    Table 1: Celgene - Key Facts 6
    Table 2: Celgene - Other Locations and Subsidiaries 12
    Table 3: Celgene - Year-End Share Price and Market Capitalization, 2002-2006 ($) 13
    Table 4: Celgene - Key Events Impacting Share Price Performance 14
    Table 5: Celgene - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 15
    Table 6: Celgene - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues) 18
    Table 7: Celgene – Balance Sheet, 2002-2006 ($ Mn) 19
    Table 8: Celgene – Cash Flow, 2002-2006 ($ Mn) 19
    Table 9: Celgene - Revenue Breakdown, 2002-2006 ($ Mn) 20
    Table 10: Celgene - Geographic Breakdown, 2002-2006 ($ Mn) 22
    Table 11: Celgene - Marketed Products 23
    Table 12: Celgene - In-house Pipeline Products 26
    Table 13: Celgene - Historical Product Sales, 2002-2006 ($ Mn) 29
    Table 14: Celgene - Forecast Sales, 2006-2010 ($ Mn) 30
    Table 15: Celgene – Key Competitors 32
    Table 16: Celgene – Key Suppliers 33
    Table 17: Celgene – Key Clients 33
    Table 18: Celgene - Key Shareholders 34
    Table 19: Celgene - SWOT Analysis Summary 39
    Table 20: Celgene - Value Chain Analysis 46
    Table 21: Celgene - Scorecard 48
    Table 22: Celgene – Key Employees 50
    Table 23: Celgene – Financial and Operational Overview 55
    Table 24: Celgene - Key Industry Specific Ratios 57